Status:
COMPLETED
Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Menstrual Cup
Intrauterine Device Migration
Eligibility:
All Genders
18+ years
Brief Summary
In France, 26% of women of childbearing age use an intrauterine device (IUD) containing copper or levonorgestrel as a method of contraception. Failures of IUD contraception are mainly due to shifting ...
Eligibility Criteria
Inclusion
- Patient aged 18 or over
- Consultant for one of the following reasons:
- IUD control
- IUD expulsion
- Pregnancy on IUD
- Other reason that required an ultrasound for the IUD
- Consent to participate in the study
Exclusion
- Patient benefiting from a legal protection measure
Key Trial Info
Start Date :
March 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 17 2021
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT04782583
Start Date
March 18 2020
End Date
May 17 2021
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
cabinet IPSO
Paris, France, 75003